Shukra Pharmaceuticals Limited (BOM:524632)

India flag India · Delayed Price · Currency is INR
21.58
+0.42 (1.98%)
At close: Jul 16, 2025
Market Cap9.27B
Revenue (ttm)367.94M
Net Income (ttm)95.75M
Shares Out437.88M
EPS (ttm)0.22
PE Ratio96.18
Forward PEn/a
Dividend0.10 (0.48%)
Ex-Dividend DateSep 23, 2024
Volume84,218
Average Volume200,371
Open21.58
Previous Close21.16
Day's Range21.58 - 21.58
52-Week Range5.75 - 27.15
Beta0.26
RSI86.38
Earnings DateAug 12, 2025

About Shukra Pharmaceuticals

Shukra Pharmaceuticals Limited develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antib... [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 182
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524632
Full Company Profile

Financial Performance

In 2024, Shukra Pharmaceuticals's revenue was 367.94 million, a decrease of -51.88% compared to the previous year's 764.66 million. Earnings were 95.75 million, a decrease of -48.35%.

Financial Statements

News

Shukra Pharmaceuticals rises nearly 2% as company opens four new branch offices

Shares of Shukra Pharmaceuticals Limited rose nearly 2% to ₹19.57 today after the company announced the opening of four new branch offices in major Indian cities — Mumbai, Gurgaon (NCR), Bangalore, an...

6 days ago - Business Upturn

Shukra Pharmaceuticals opens new branch offices in Mumbai, Gurgaon, Bangalore, and Kolkata to boost market reach

Shukra Pharmaceuticals Limited announced the opening of four new branch offices in key Indian cities — Mumbai, Gurgaon (NCR), Bangalore, and Kolkata — as part of its strategic growth initiative aimed ...

6 days ago - Business Upturn

Shukra Pharmaceuticals shares surge 90% in past one month; Check details

Shukra Pharmaceuticals has witnessed a dramatic surge in its stock price, rising by an impressive 90% in the past month. As of January 24, 2025, the stock closed at 224.60. Performance Breakdown: Shuk...

6 months ago - Business Upturn

Shukra Pharmaceuticals shares surge 166% in past one month; Check details

Shukra Pharmaceuticals has witnessed a remarkable surge in its stock price, with shares rising by an astounding 166% over the past month. As of January 10, 2025, the stock closed at ₹184.45, marking a...

6 months ago - Business Upturn